213 related articles for article (PubMed ID: 33055300)
1. PRKACB variants in skeletal disease or adrenocortical hyperplasia: effects on protein kinase A.
Espiard S; Drougat L; Settas N; Haydar S; Bathon K; London E; Levy I; Faucz FR; Calebiro D; Bertherat J; Li D; Levine MA; Stratakis CA
Endocr Relat Cancer; 2020 Nov; 27(11):647-656. PubMed ID: 33055300
[TBL] [Abstract][Full Text] [Related]
2. Germline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple Congenital Malformation Syndrome.
Palencia-Campos A; Aoto PC; Machal EMF; Rivera-Barahona A; Soto-Bielicka P; Bertinetti D; Baker B; Vu L; Piceci-Sparascio F; Torrente I; Boudin E; Peeters S; Van Hul W; Huber C; Bonneau D; Hildebrand MS; Coleman M; Bahlo M; Bennett MF; Schneider AL; Scheffer IE; Kibæk M; Kristiansen BS; Issa MY; Mehrez MI; Ismail S; Tenorio J; Li G; Skålhegg BS; Otaify GA; Temtamy S; Aglan M; Jønch AE; De Luca A; Mortier G; Cormier-Daire V; Ziegler A; Wallis M; Lapunzina P; Herberg FW; Taylor SS; Ruiz-Perez VL
Am J Hum Genet; 2020 Nov; 107(5):977-988. PubMed ID: 33058759
[TBL] [Abstract][Full Text] [Related]
3. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
Libé R; Horvath A; Vezzosi D; Fratticci A; Coste J; Perlemoine K; Ragazzon B; Guillaud-Bataille M; Groussin L; Clauser E; Raffin-Sanson ML; Siegel J; Moran J; Drori-Herishanu L; Faucz FR; Lodish M; Nesterova M; Bertagna X; Bertherat J; Stratakis CA
J Clin Endocrinol Metab; 2011 Jan; 96(1):E208-14. PubMed ID: 21047926
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
[TBL] [Abstract][Full Text] [Related]
5. Carney complex: an update.
Correa R; Salpea P; Stratakis CA
Eur J Endocrinol; 2015 Oct; 173(4):M85-97. PubMed ID: 26130139
[TBL] [Abstract][Full Text] [Related]
6. PRKACA: the catalytic subunit of protein kinase A and adrenocortical tumors.
Berthon AS; Szarek E; Stratakis CA
Front Cell Dev Biol; 2015; 3():26. PubMed ID: 26042218
[TBL] [Abstract][Full Text] [Related]
7. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
Louiset E; Stratakis CA; Perraudin V; Griffin KJ; Libé R; Cabrol S; Fève B; Young J; Groussin L; Bertherat J; Lefebvre H
J Clin Endocrinol Metab; 2009 Jul; 94(7):2406-13. PubMed ID: 19383776
[TBL] [Abstract][Full Text] [Related]
8. Differential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a.
Yin Z; Pringle DR; Jones GN; Kelly KM; Kirschner LS
Mol Endocrinol; 2011 Oct; 25(10):1786-93. PubMed ID: 21852354
[TBL] [Abstract][Full Text] [Related]
9. A large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer.
Anselmo J; Medeiros S; Carneiro V; Greene E; Levy I; Nesterova M; Lyssikatos C; Horvath A; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2012 Feb; 97(2):351-9. PubMed ID: 22112814
[TBL] [Abstract][Full Text] [Related]
10. PKA Cβ: a forgotten catalytic subunit of cAMP-dependent protein kinase opens new windows for PKA signaling and disease pathologies.
Taylor SS; Wallbott M; Machal EMF; Søberg K; Ahmed F; Bruystens J; Vu L; Baker B; Wu J; Raimondi F; Ongeri EM; Herberg FW; Skålhegg BS
Biochem J; 2021 Jun; 478(11):2101-2119. PubMed ID: 34115095
[TBL] [Abstract][Full Text] [Related]
11. Activating PRKACB somatic mutation in cortisol-producing adenomas.
Espiard S; Knape MJ; Bathon K; Assié G; Rizk-Rabin M; Faillot S; Luscap-Rondof W; Abid D; Guignat L; Calebiro D; Herberg FW; Stratakis CA; Bertherat J
JCI Insight; 2018 Apr; 3(8):. PubMed ID: 29669941
[TBL] [Abstract][Full Text] [Related]
12. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase A defects and cortisol-producing adrenal tumors.
Zilbermint M; Stratakis CA
Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):157-62. PubMed ID: 25871963
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
[TBL] [Abstract][Full Text] [Related]
15. ARMC5 variants in PRKAR1A-mutated patients modify cortisol levels and Cushing's syndrome.
Maria AG; Tatsi C; Berthon A; Drougat L; Settas N; Hannah-Shmouni F; Bertherat J; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Sep; 27(9):509-517. PubMed ID: 32638579
[TBL] [Abstract][Full Text] [Related]
16. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
18. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A alterations in adrenocortical tumors.
Espiard S; Ragazzon B; Bertherat J
Horm Metab Res; 2014 Nov; 46(12):869-75. PubMed ID: 25105543
[TBL] [Abstract][Full Text] [Related]
20. Molecular Genetic and Genomic Alterations in Cushing's Syndrome and Primary Aldosteronism.
Kamilaris CDC; Stratakis CA; Hannah-Shmouni F
Front Endocrinol (Lausanne); 2021; 12():632543. PubMed ID: 33776926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
